§ 16-42-23-1 — Health care facilities; restrictions on use

Except as provided in section 8 of this
chapter, a hospital or other health care facility may not interfere with
the physician-patient relationship by restricting or forbidding the use
of amygdalin (laetrile) as an adjunct to recognized, customary, or
accepted modes of therapy in the treatment of any malignancy, disease,
illness, or physical condition if the following conditions exist:
(1) Amygdalin (laetrile) is prescribed or administered by a
physician holding an unlimited license for the practice of
medicine in Indiana.
(2) The patient has signed the "written informed request" as set
forth in section 5 of this chapter.
[Pre-1993 Recodification Citation: 16-8-8-1.]

Legislative History

As added by P.L.2-1993, SEC.25.